INGR
Ingredion Incorporated NYSE Listed Dec 11, 1997$97.93
-0.92%
vs $98.84
Mkt Cap $6.4B
52w Low $97.93
0.0% of range
52w High $139.23
50d MA $106.20
200d MA $112.93
P/E (TTM)
8.8x
EV/EBITDA
5.8x
P/B
1.4x
Debt/Equity
0.4x
ROE
3.9%
P/FCF
12.5x
RSI (14)
35.70
ATR (14)
$2.43
Beta
0.69
50d MA
$106.20
200d MA
$112.93
Avg Volume
1.0M
Ingredion Incorporated, together with its subsidiaries, produces and sells starches and sweeteners for various industries. It operates through four segments: North America; South America; Asia-Pacific; and Europe, Middle East and Africa. The company offers sweetener products comprising glucose syrups, high maltose syrups, high fructose corn syrups, caramel colors, dextrose, polyols, maltodextrins, and glucose syrup solids, as well as food-grade and industrial starches, biomaterials, and nutrition ingredients. It also provides edible corn oil; refined corn oil to packers of cooking oil and to producers of margarine, salad dressings, shortening, mayonnaise, and other foods; and corn gluten feed used as protein feed for chickens, pet food, and aquaculture, as well as fruit and vegetable products, such as concentrates, purees and essences, pulse proteins, and hydrocolloids systems and blends. The company's products are derived primarily from processing corn and other starch-based materials, such as tapioca, potato, and rice. It serves food, beverage, brewing, and animal nutrition industries. The company was formerly known as Corn Products International, Inc. and changed its name to Ingredion Incorporated in June 2012. Ingredion Incorporated was founded in 1906 and is headquartered in Westchester, Illinois.
5 Westbrook Corporate Center · Westchester, IL 60154 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | TNS | 2.44 | 2.34 | -4.1% | 107.13 | +0.5% | -0.7% | +0.9% | +0.0% | -1.1% | +0.5% | — |
| Feb 3, 2026 | TNS | 2.59 | 2.53 | -2.3% | 120.41 | +0.4% | -0.4% | +0.0% | -0.9% | +1.0% | -0.7% | — |
| Nov 4, 2025 | TNS | 2.73 | 2.75 | +0.7% | 107.40 | +0.1% | +0.3% | +0.0% | -1.2% | +1.9% | -1.0% | — |
| Aug 1, 2025 | TNS | 2.78 | 2.87 | +3.2% | 126.37 | +0.8% | +0.2% | +0.0% | -0.2% | -0.9% | +0.9% | — |
| May 6, 2025 | TNS | 2.44 | 2.97 | +21.7% | 138.44 | -0.1% | -2.0% | +0.0% | +1.1% | -0.1% | +0.1% | — |
| Feb 4, 2025 | TNS | 2.54 | 2.63 | +3.5% | 127.13 | -0.7% | -0.7% | +0.0% | +0.9% | +0.4% | -0.3% | — |
| Nov 5, 2024 | TNS | 2.58 | 3.05 | +18.2% | 154.86 | -0.2% | -2.8% | +0.0% | -0.3% | +1.0% | -1.2% | — |
| Aug 6, 2024 | TNS | 2.49 | 2.87 | +15.3% | 127.95 | +0.5% | -1.2% | +0.0% | +0.3% | +2.7% | -1.5% | — |
| May 8, 2024 | TNS | 2.06 | 2.08 | +1.0% | 118.45 | +0.4% | +1.3% | +0.0% | +0.2% | +1.0% | -2.7% | — |
| Feb 6, 2024 | TNS | 1.87 | 1.97 | +5.3% | 109.71 | +0.0% | +0.9% | +0.0% | -1.1% | -1.2% | +0.8% | — |
| Nov 7, 2023 | TNS | 1.95 | 2.33 | +19.5% | 101.83 | -0.1% | -1.8% | +0.0% | +1.4% | +1.0% | -0.1% | — |
| Aug 8, 2023 | TNS | 2.33 | 2.32 | -0.4% | 101.03 | +0.0% | +0.0% | +0.0% | -1.1% | -1.3% | -0.1% | — |
| May 3, 2023 | BMO | 2.01 | 2.80 | +39.3% | 109.95 | -0.3% | -1.3% | +0.0% | -0.1% | -0.0% | +0.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9 | Oppenheimer | Downgrade | Outperform → Perform | — | $99.66 | $97.66 | -2.0% | +2.0% | +0.9% | -1.6% | +0.7% | -0.1% |
| Apr 22 | Oppenheimer | Maintains | Outperform → Outperform | — | $113.20 | $113.26 | +0.1% | -0.5% | +0.2% | -0.2% | +0.3% | +0.0% |
| Apr 9 | UBS | Maintains | Neutral → Neutral | — | $113.56 | $112.94 | -0.5% | +1.2% | -0.2% | -0.9% | -0.5% | -0.3% |
| Feb 5 | UBS | Maintains | Neutral → Neutral | — | $119.96 | $119.28 | -0.6% | -0.9% | +1.0% | -0.7% | -0.5% | +1.0% |
| Feb 4 | Barclays | Maintains | Equal Weight → Equal Weight | — | $120.41 | $120.92 | +0.4% | -0.4% | -0.9% | +1.0% | -0.7% | -0.5% |
| Feb 4 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $120.41 | $120.92 | +0.4% | -0.4% | -0.9% | +1.0% | -0.7% | -0.5% |
| Nov 6 | Barclays | Downgrade | Overweight → Equal Weight | — | $107.70 | $105.75 | -1.8% | -1.2% | +1.9% | -1.0% | +1.8% | -1.0% |
| Nov 5 | UBS | Maintains | Neutral → Neutral | — | $107.40 | $107.49 | +0.1% | +0.3% | -1.2% | +1.9% | -1.0% | +1.8% |
| Nov 5 | BMO Capital | Maintains | Market Perform → Market Perform | — | $107.40 | $107.49 | +0.1% | +0.3% | -1.2% | +1.9% | -1.0% | +1.8% |
| Nov 5 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $107.40 | $107.49 | +0.1% | +0.3% | -1.2% | +1.9% | -1.0% | +1.8% |
| Oct 6 | UBS | Maintains | Neutral → Neutral | — | $120.87 | $120.23 | -0.5% | -0.5% | +0.3% | +0.9% | -1.7% | +0.2% |
| Jul 9 | UBS | Maintains | Neutral → Neutral | — | $136.73 | $137.56 | +0.6% | -0.5% | +0.2% | -0.5% | +0.3% | -1.3% |
| Apr 22 | Oppenheimer | Maintains | Outperform → Outperform | — | $128.41 | $128.91 | +0.4% | +1.8% | -0.4% | -0.1% | +0.1% | +0.7% |
| Apr 7 | UBS | Downgrade | Buy → Neutral | — | $130.89 | $127.88 | -2.3% | -4.3% | -1.6% | +4.0% | -0.5% | +1.9% |
| Feb 5 | Oppenheimer | Maintains | Outperform → Outperform | — | $127.13 | $126.26 | -0.7% | -0.7% | +0.9% | +0.4% | -0.3% | +0.9% |
| Feb 5 | BMO Capital | Maintains | Market Perform → Market Perform | — | $127.13 | $126.26 | -0.7% | -0.7% | +0.9% | +0.4% | -0.3% | +0.9% |
| Feb 5 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $127.13 | $126.26 | -0.7% | -0.7% | +0.9% | +0.4% | -0.3% | +0.9% |
| Nov 15 | UBS | Maintains | Buy → Buy | — | $149.19 | $148.73 | -0.3% | -5.6% | -1.4% | +2.3% | +0.3% | +1.4% |
| Nov 6 | Barclays | Maintains | Overweight → Overweight | — | $154.86 | $154.51 | -0.2% | -2.8% | -0.3% | +1.0% | -1.2% | +0.4% |
| Nov 6 | Oppenheimer | Maintains | Outperform → Outperform | — | $154.86 | $154.51 | -0.2% | -2.8% | -0.3% | +1.0% | -1.2% | +0.4% |
| Nov 6 | BMO Capital | Maintains | Market Perform → Market Perform | — | $154.86 | $154.51 | -0.2% | -2.8% | -0.3% | +1.0% | -1.2% | +0.4% |
| Oct 21 | Oppenheimer | Maintains | Outperform → Outperform | — | $134.26 | $134.35 | +0.1% | -0.2% | +0.3% | +1.2% | -0.3% | -0.4% |
| Aug 15 | UBS | Maintains | Buy → Buy | — | $130.88 | $131.52 | +0.5% | -0.1% | +0.2% | +1.0% | -0.4% | +0.5% |
| Aug 9 | Barclays | Upgrade | Equal Weight → Overweight | — | $126.76 | $128.40 | +1.3% | +2.7% | -1.5% | +1.2% | +0.9% | -0.1% |
| Aug 7 | Oppenheimer | Maintains | Outperform → Outperform | — | $127.95 | $128.54 | +0.5% | -1.2% | +0.3% | +2.7% | -1.5% | +1.2% |
| Aug 7 | BMO Capital | Maintains | Market Perform → Market Perform | — | $127.95 | $128.54 | +0.5% | -1.2% | +0.3% | +2.7% | -1.5% | +1.2% |
| May 9 | BMO Capital | Maintains | Market Perform → Market Perform | — | $118.45 | $118.98 | +0.4% | +1.3% | +0.2% | +1.0% | -2.7% | -0.4% |
| Mar 6 | Barclays | Maintains | Equal Weight → Equal Weight | — | $116.71 | $117.24 | +0.5% | -0.3% | -0.0% | +1.0% | +0.1% | +0.3% |
| Feb 16 | Goldman Sachs | Maintains | Buy → Buy | — | $114.91 | $114.79 | -0.1% | -0.6% | +1.5% | -0.6% | -0.4% | +0.2% |
| Feb 15 | Goldman Sachs | Upgrade | Neutral → Buy | — | $110.79 | $113.09 | +2.1% | +3.7% | -0.6% | +1.5% | -0.6% | -0.4% |
| Feb 7 | Stephens & Co. | Maintains | Overweight → Overweight | — | $109.71 | $109.75 | +0.0% | +0.9% | -1.1% | -1.2% | +0.8% | -0.6% |
| Nov 13 | UBS | Maintains | Buy → Buy | — | $102.39 | $102.50 | +0.1% | -0.1% | +0.9% | +0.3% | -0.7% | +0.4% |
| Nov 8 | Stephens & Co. | Maintains | Overweight → Overweight | — | $101.83 | $101.71 | -0.1% | -1.8% | +1.4% | +1.0% | -0.1% | +0.9% |
| Nov 1 | Barclays | Maintains | Equal Weight → Equal Weight | — | $93.58 | $93.22 | -0.4% | -0.5% | +2.0% | +1.1% | -0.3% | +6.5% |
| Aug 9 | BMO Capital | Maintains | Market Perform → Market Perform | — | $101.03 | $101.06 | +0.0% | +0.0% | -1.1% | -1.3% | -0.1% | -1.0% |
| Aug 9 | Stephens & Co. | Maintains | Overweight → Overweight | — | $101.03 | $101.06 | +0.0% | +0.0% | -1.1% | -1.3% | -0.1% | -1.0% |
| Jun 1 | Barclays | Maintains | Equal Weight → Equal Weight | — | $104.60 | $104.43 | -0.2% | +0.9% | +1.9% | -1.4% | +0.4% | +0.5% |
| May 4 | Barclays | Maintains | Equal Weight → Equal Weight | — | $109.95 | $109.67 | -0.3% | -1.3% | -0.1% | -0.0% | +0.0% | +1.4% |
| May 4 | BMO Capital | Maintains | Market Perform → Market Perform | — | $109.95 | $109.67 | -0.3% | -1.3% | -0.1% | -0.0% | +0.0% | +1.4% |
| May 4 | Stephens & Co. | Maintains | Overweight → Overweight | — | $109.95 | $109.67 | -0.3% | -1.3% | -0.1% | -0.0% | +0.0% | +1.4% |
| Apr 13 | UBS | Upgrade | Neutral → Buy | — | $101.56 | $103.74 | +2.1% | +4.6% | -1.1% | -0.3% | +0.2% | +0.5% |
| Mar 17 | Stephens & Co. | Maintains | Overweight → Overweight | — | $96.21 | $95.63 | -0.6% | +0.4% | +1.9% | +1.3% | -1.9% | +0.2% |
| Feb 9 | Credit Suisse | Maintains | Neutral → Neutral | — | $101.02 | $101.23 | +0.2% | -3.1% | +1.0% | +0.3% | -0.5% | +0.1% |
| Jan 23 | Barclays | Downgrade | Overweight → Equal Weight | — | $102.15 | $101.18 | -0.9% | -0.9% | +0.1% | +1.2% | +0.1% | -1.3% |
| Jan 17 | Stephens & Co. | Upgrade | Equal Weight → Overweight | — | $100.15 | $101.25 | +1.1% | +4.3% | -2.0% | +0.2% | -0.3% | -0.9% |
| Nov 7 | Credit Suisse | Maintains | Neutral → Neutral | — | $93.19 | $93.76 | +0.6% | -0.0% | -0.1% | -1.1% | +2.5% | -1.9% |
| Sep 30 | UBS | Maintains | Neutral → Neutral | — | $82.09 | $82.04 | -0.1% | -1.9% | +1.5% | +2.5% | -2.1% | -1.5% |
| Apr 12 | Credit Suisse | Downgrade | Outperform → Neutral | — | $90.12 | $88.73 | -1.5% | -2.8% | +1.0% | +1.2% | -0.5% | +1.4% |
| Nov 9 | Barclays | Maintains | Overweight → Overweight | — | $99.03 | $99.45 | +0.4% | +0.7% | +0.9% | -1.2% | -0.1% | +0.8% |
| Nov 3 | Credit Suisse | Upgrade | Neutral → Outperform | — | $92.51 | $96.96 | +4.8% | +3.7% | +0.5% | +1.9% | +0.8% | +0.7% |
No insider trades available.
8-K · 1.01
!! High
Ingredion Incorporated -- 8-K 1.01: Material Agreement
Ingredion Incorporated entered into material agreements in June 2026 related to a Rule 2.7 announcement, though specific deal terms aren't detailed in this filing excerpt.
Jun 9
8-K
Ingredion Incorporated -- 8-K Filing
I don't have sufficient information in the provided summary to identify a specific material event or deal outcome that would impact investors. Please provide the actual 8-K details regarding what triggered the filing.
May 21
8-K · 7.01
! Medium
Ingredion Incorporated -- 8-K 7.01: Regulation FD Disclosure
May 14
8-K
Ingredion Incorporated -- 8-K Filing
Ingredion Incorporated disclosed forward-looking statements in its 8-K filing while invoking safe harbor protections under securities laws to limit liability for future projections.
May 5
8-K · 2.02
!! High
Ingredion Incorporated -- 8-K 2.02: Earnings Results
Ingredion reported first-quarter 2026 earnings results, with the company disclosing its condensed consolidated financial performance for the period ended March 31, 2026.
May 5
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
INGR's appointment of an interim CFO signals potential financial leadership instability and suggests the company is searching for a permanent replacement, which could create near-term uncertainty for investors regarding financial strategy and decision-making.
Mar 25
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A director compensation arrangement change suggests potential governance restructuring; investors should monitor whether this reflects leadership transition costs or strategic board composition shifts affecting future decision-making quality.
Mar 23
8-K · 8.01
!! High
Ingredion Incorporated -- 8-K 8.01: Material Event / Announcement
Ingredion's board consolidated leadership by naming CEO James P. Zallie as chairman, strengthening executive authority but potentially raising governance independence concerns for investors.
Feb 11
8-K
Ingredion Incorporated -- 8-K Filing
Ingredion's record full-year results were propelled by strong Texture Healthful Solutions and LATAM Food Industrial Ingredients performance, though U.S. Food Industrial Ingredients recovery lagged expectations.
Feb 3
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Portfolio Management Llc | 4,651,464 | $524M | New | Mar 2026 |
| 2 | First Trust Advisors Lp | 3,054,149 | $344M | Added | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 2,812,365 | $317M | New | Mar 2026 |
| 4 | Aqr Capital Management Llc | 2,205,974 | $248M | Added | Mar 2026 |
| 5 | Morgan Stanley | 1,959,754 | $216M | Added | Dec 2025 |
| 6 | Fmr Llc | 1,525,285 | $172M | Added | Mar 2026 |
| 7 | Yacktman Asset Management Lp | 1,440,258 | $162M | Added | Mar 2026 |
| 8 | Cooke & Bieler Lp | 1,143,357 | $129M | Reduced | Mar 2026 |
| 9 | Quantinno Capital Management Lp | 930,771 | $105M | Added | Mar 2026 |
| 10 | Equity Investment Corp | 846,456 | $95M | Added | Mar 2026 |
| 11 | Invesco Ltd. | 758,152 | $85M | — | Mar 2026 |
| 12 | Principal Financial Group Inc | 707,339 | $78M | Added | Dec 2025 |
| 13 | Assetmark, Inc | 665,228 | $73M | Added | Dec 2025 |
| 14 | Bank Of New York Mellon Corp | 625,876 | $71M | Reduced | Mar 2026 |
| 15 | Two Sigma Investments, Lp | 624,498 | $70M | Added | Mar 2026 |
| 16 | Nordea Investment Management Ab | 626,917 | $70M | Added | Mar 2026 |
| 17 | Northern Trust Corp | 581,744 | $66M | Reduced | Mar 2026 |
| 18 | Ubs Group Ag | 549,959 | $62M | Added | Mar 2026 |
| 19 | Acadian Asset Management Llc | 528,843 | $60M | — | Mar 2026 |
| 20 | Bank Of America Corp /de/ | 501,948 | $57M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$6.39B
Enterprise Value
$7.09B
P/E (TTM)
8.76x
Forward P/E
8.72x
PEG Ratio
0.65x
P/B
1.44x
P/S
0.88x
P/FCF
12.50x
EV/EBITDA
5.75x
Shares Out
65.2M
Financials (TTM)
Revenue
$7.22B
Net Income
$729.0M
EBITDA
$1.23B
Free Cash Flow
$511.0M
Op Cash Flow
$944.0M
EPS Basic
$11.36
EPS Diluted
$11.18
EPS Forward
$11.24
Gross Margin
25.3%
Op Margin
14.0%
Net Margin
10.1%
Balance Sheet
Total Assets
$7.90B
Total Liab.
$3.53B
Total Equity
$4.37B
Cash
$1.03B
LT Debt
$1.74B
Book Value/Sh
$68.01
Debt/Equity
0.41x
Current Ratio
2.66
Quick Ratio
1.73
Returns & Growth
ROE
3.9%
ROA
2.1%
ROIC
11.6%
Rev Growth YoY
-2.8%
EPS Growth YoY
+15.0%
Price Returns
2W
-0.8%
1M
-9.2%
3M
-13.6%
6M
-5.7%
12M
-27.1%
Technicals
52W High
$139.23
52W Low
$97.93
50d MA
$106.20
200d MA
$112.93
RSI (14)
35.70
ATR (14)
$2.43
Beta
0.69
Avg Volume
1.0M
Dividends
Div Rate
$3.29
Div Yield
3.0%
Frequency
4
Ex-Div Date
Apr 1, 2026
Analyst Price Targets
Consensus
$124.25
High
$128.00
Low
$122.00
Median
$123.50
Data updated apr 25, 2026 3:37pm
· Source: financialmodelingprep.com